CMS (Centers for Medicare and Medicaid Services) releases data for 2003 OP (outpatient) reimbursement changes
This article was originally published in Clinica
The Centers for Medicare and Medicaid Services (CMS) has agreed to release the data it will use to determine Medicare's 2003 reimbursement rates for outpatient (OP) services, giving device companies adequate time to identify any anomalies and deficiencies in need of correction.
You may also be interested in...
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.